Innobiovir

INNOBIOVIR is the synergetic alliance between two cutting-edge academic laboratories (LAGEPP, VirPath) and two training centres (IPIL, IUT Lyon 1), aiming to propose cross-competency expertises in the fields of bioproduction, formulation and evaluation of viral antigens and bio-compounds. Addressed to both public and private innovators in the field of public health, INNOBIOVIR combines competencies all along the value chain of product and process development, with a particular focus on viral production and galenic methods. INNOBIOVIR deploys its capabilities over more than 500 m2 of technical floors, including BioSafety Level 2 and 3 facilities to support R&D projects, realization of on-demand services and advanced trainings.